Robert G. Goetze

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Albrecht Neeße · 4 shared papers, 2018–2024 · strength 0.46
   • Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002↗
   • Paper Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Mode… DOI 10.3791/56979↗
   • Paper Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer. DOI 10.3390/cells8060563↗
2. Elisabeth Heßmann · 4 shared papers, 2018–2024 · strength 0.46
   • Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002↗
   • Paper Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Mode… DOI 10.3791/56979↗
   • Paper Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer. DOI 10.3390/cells8060563↗
3. Volker Ellenrieder · 4 shared papers, 2018–2024 · strength 0.46
   • Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002↗
   • Paper Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Mode… DOI 10.3791/56979↗
   • Paper Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer. DOI 10.3390/cells8060563↗
4. Shiv K. Singh · 2 shared papers, 2019–2024 · strength 0.30
   • Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002↗
   • Paper Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer. DOI 10.3390/cells8060563↗
5. Shilpa Patil · 3 shared papers, 2018–2019 · strength 0.26
   • Paper Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Mode… DOI 10.3791/56979↗
   • Paper Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer. DOI 10.3390/cells8060563↗
   • Paper Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intr… DOI 10.1016/j.ebiom.2019.01.037↗
6. Lisa Knoll · 1 shared paper, 2024 · strength 0.21
   • Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002↗
7. Christoph Ammer‐Herrmenau · 1 shared paper, 2024 · strength 0.21
   • Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002↗
8. Markus Schirmer · 1 shared paper, 2019 · strength 0.09
   • Paper Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer. DOI 10.3390/cells8060563↗
9. Melanie S. Patzak · 1 shared paper, 2019 · strength 0.08
   • Paper Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intr… DOI 10.1016/j.ebiom.2019.01.037↗
10. Thomas Knösel · 1 shared paper, 2019 · strength 0.08
    • Paper Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intr… DOI 10.1016/j.ebiom.2019.01.037↗
11. Jochen Gaedcke · 1 shared paper, 2019 · strength 0.08
    • Paper Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intr… DOI 10.1016/j.ebiom.2019.01.037↗
12. Steven A. Johnsen · 1 shared paper, 2019 · strength 0.08
    • Paper Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intr… DOI 10.1016/j.ebiom.2019.01.037↗
13. Feda H. Hamdan · 1 shared paper, 2019 · strength 0.08
    • Paper Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intr… DOI 10.1016/j.ebiom.2019.01.037↗
14. Christian P. Pilarsky · 1 shared paper, 2019 · strength 0.08
    • Paper Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intr… DOI 10.1016/j.ebiom.2019.01.037↗
15. Frances M. Richards · 1 shared paper, 2019 · strength 0.08
    • Paper Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intr… DOI 10.1016/j.ebiom.2019.01.037↗
16. Duncan Ian Jodrell · 1 shared paper, 2019 · strength 0.08
    • Paper Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intr… DOI 10.1016/j.ebiom.2019.01.037↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.